- Deutsche Bank Maintains Hold on Entegris, Raises Price Target to $160
- ‘We believe ReneSola is a Fraudulent Company; Most Projects Never Existed’ -Short Report From Grizzly Research
- Why Uber Shares Are Rising
- USA EIA Natural Gas Inventories for Nov 26 Draw 59 bcf vs Draw 57 bcf Est; Prior Draw 21 bcf
- Vir Biotechnology shares were trading higher after the company, and GlaxoSmithKline, announced preclinical data demonstrated sotrovimab retains activity against key omicron mutations.